Skip to content

Why ATA

When accuracy matters, clinical teams turn to ATA.

ATA is the trusted partner for molecular lab interpretation and therapeutic guidance. Our team of molecular pharmacists interprets PCR lab reports to identify pathogens, assess resistance genes, and deliver clear, science-backed recommendations—customized for each patient.

Built for Clinical Decision-Makers

We are not a software tool. We are practicing professionals who understand what it takes to make accurate therapeutic choices under pressure. Every ATA report reflects clinical judgment, translating resistant gene data into real-world prescribing guidance that helps providers treat the right pathogen with the right antibiotic—faster and with more confidence.

Designed by Molecular Pharmacists, for Providers

We developed our panels, reports, and protocols with one question in mind:
What would make this easier and more actionable for the provider?

ATA’s Therapeutic Guidance Reports are:

Clear

One-page, easy-to-read summaries

Comprehensive

Pathogen ID, resistance genes, and recommendations

Actionable

ATA has developed a proprietary method for predicting antimicrobial therapy. 

Custom

Tailored to each patient’s clinical scenario

Our success rate outpaces common automated tools because we individualize treatment plans based on multiple data points.

2 Million+ reports completed

20+ doctorate-level pharmacists

Proven improvement over algorithm-based guidance

800,000+ workflows with resistance gene detection

What Sets Us Apart

Live Clinical Support

Our pharmacists are available to answer therapeutic questions in real-time.

Antibiotic Stewardship

Every recommendation supports proper antibiotic use and helps combat resistance.

Cost-Conscious Approach

We provide unmatched value for the level of clinical depth offered.

Collaborative Model

Designed to work hand-in-hand with labs, management groups, and provider teams.

You Handle the Patient. We’ll Handle the Interpretation.

Partner with ATA and get clinical clarity backed by molecular pharmacists.